HPVC2026-058: Pharmaceutical Products

Update: 28th September 2026

HSV has made an update to the Pharmaceutical Products (HPVC2026-058). Please find the updated information below:

Upcoming Procurement Activity

Upcoming Supplementary Tender #003

Market Release Date: 28 September 2026

Market Closing Date: 19 October 2026

Title: HPVITS2026-058.003 Pharmaceutical Products – Supplementary 003

Scope for Supplementary 003:

268.02 – Macrogol 3350 with Electrolytes Adult Powder Sachet Flavour Free, 30

334.01 – Paclitaxel (as nanoparticle albumin-bound) 100 mg Injection, Ampoule/Vial

359.03 – Posaconazole 300 mg Injection, Ampoule/Vial

489.01 – Dobutamine 250 mg/20 mL Injection, Ampoule/Vial

490.01 – Eltrombopag 25 mg Tablet, 28

490.02 – Eltrombopag 50 mg Tablet, 28

491.01 – Nilotinib 150 mg Capsule, 120

491.02 – Nilotinib 200 mg Capsule, 120

6002.01 – Aflibercept 40 mg/mL Injection, Syringe

All enquiries regarding this supplementary tender prior to the market release date should be directed to sheerin.kaur@healthsharevic.org.au.

Once the tender has been released, please direct all correspondence through the HSV Procurement Portal.

Important Note:

Please ensure you are registered to access the Procurement Portal and your details are up to date. More information can be found on the HSV website, or contact:

HSV Helpdesk

Phone: (03) 9947 3900

Email: helpdesk@healthsharevic.org.au

Tentative Dates

Announcement of outcome to suppliers: 27 November 2026

Announcement of outcome to health services: 16 December 2026

Contract Commencement Date: 1 February 2027